Spartan Gio

The future is AI. Industrial Engineer 🇮🇹. Stock investor

[Spartan Gio @GalixGiorgio]

@ARK_Funds $RXRX personalized oncology
REC-7735 is the clearest example: it targets the specific PI3Kα H1047R mutation, so the drug is being developed for a genetically defined subset of cancer patients. REC-1245 too

[Spartan Gio @GalixGiorgio]

@W0rkerOfSecrets Potential yes - and a catalyst is on second of November - Rec4881 drug, update . Hope your chart is aligning with this

[Spartan Gio @GalixGiorgio]

@iTzHugoBOSS @EchoAnalysis lol 🤣

[Spartan Gio @GalixGiorgio]

@LongBullz $rxrx dancing with SMA200

[Spartan Gio @GalixGiorgio]

@RecursionPharma @FiercePharma Another external validation of the Recursion OS — and importantly, Fierce highlights REC-4881 as its first clinical validation. Congrats team! 🔥 $RXRX

[Spartan Gio @GalixGiorgio]

@unusual_whales $RXRX we will be part of it

[Spartan Gio @GalixGiorgio]

@EchoAnalysis $rxrx thanks for updating it

[Spartan Gio @GalixGiorgio]

@TingMA340293 Hi Martin - Italy 🇮🇹
I am confident they can transform AI into first-in-class medicines.

[Spartan Gio @GalixGiorgio]

@goo1million that's my idea too- that could turn out soon

[Spartan Gio @GalixGiorgio]

@midascabal @asymmetrix_xyz $RXRX

[Spartan Gio @GalixGiorgio]

@LSbyMO What a fantastic combo

[Spartan Gio @GalixGiorgio]

@RecursionPharma @hoifungpoon @MSFTResearch What a dream team - let’s deliver together !

[Spartan Gio @GalixGiorgio]

@BritaBelli @saranormous Really enjoyed this one. It’s a good reminder that owning the application and the proprietary data can matter as much as building the biggest model

[Spartan Gio @GalixGiorgio]

@paolo_gt @salmanmiah111 @fundmyfund Could this be the one that gets us out of the matrix? Time will tell. 🚀

[Spartan Gio @GalixGiorgio]

@Stockspy1 @TelJavi We hope in the same move 😅
$RXRX

[Spartan Gio @GalixGiorgio]

@EchoAnalysis $rxrx

[Spartan Gio @GalixGiorgio]

@Han_Akamatsu you got it!

[Spartan Gio @GalixGiorgio]

@TheValueTrade $RXRX - AI, data moat, pipeline. Less than 2 bln

[Spartan Gio @GalixGiorgio]

@ZaStocks Curious to hear your view on $RXRX.

It seems to have meaningful potential in the AI healthcare/biotech theme, but it’s also one of the most beaten-down and heavily shorted names in the space.
Do you think Recursion can still become a major player if REC-4881 gets clear FDA path